Corporate Announcement
Security Code : 500420    Company : TORNTPHARM    
 
Disclosure Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015Download PDFDownload XBRL
  Exchange Received Time  09/10/2019 18:18:59         Exchange Disseminated Time   09/10/2019 18:19:03              Time Taken   00:00:04
This is to inform that the Company has today received a warning letter dated 08-Oct-19 from the USFDA for its Indrad facility in Gujarat. This action follows the earlier intimation received from USFDA in August 2019, wherein the agency had classified its inspection as 'Official Action Indicated' (OAI).

We will be engaging with the agency and are fully committed in resolving this issue at the earliest. The Company is also committed to maintaining the highest standards of compliances and quality manufacturing across all its facilities.

The Company does not believe that the warning letter will have an impact of disruption of supplies or the existing revenues from operations of this facility.

This is for your information and record.
 

Disclaimer

Back To Announcements